Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13,080,549
-
Total 13F shares
-
16,442,698
-
Share change
-
+1,119,074
-
Total reported value
-
$1,363,355,862
-
Put/Call ratio
-
33%
-
Price per share
-
$82.94
-
Number of holders
-
144
-
Value change
-
+$96,123,092
-
Number of buys
-
76
-
Number of sells
-
69
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q1 2017
As of 31 Mar 2017 EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) had 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,442,698 shares of stock of the company.
Largest 10 holders included ProQuest Associates IV LLC, JANUS CAPITAL MANAGEMENT LLC, BlackRock Inc., VICTORY CAPITAL MANAGEMENT INC, Hudson Executive Capital LP, IRIDIAN ASSET MANAGEMENT LLC/CT, ORBIMED ADVISORS LLC, First Eagle Investment Management, LLC, STATE STREET CORP, and JW Asset Management, LLC.
This table shows 144 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.